Coronavirus | Hydroxychloroquine clinical trials will resume, says WHO
4 years, 7 months ago

Coronavirus | Hydroxychloroquine clinical trials will resume, says WHO

The Hindu  

The World Health Organisation said on Wednesday that clinical trials of the drug hydroxychloroquine will resume, after having been suspended pending a safety review in the search for coronavirus treatments. Concerns about data British medical journal The Lancet said on Tuesday that it had concerns about data behind an influential article that found that HCQ increased the risk of death in COVID-19 patients, a conclusion that undercut scientific interest in the medicine championed by U.S. President Donald Trump. Hydroxychloroquine with PPE reduces odds of COVID-19 in health workers: ICMR researchers Hydroxychloroquine — which has anti-inflammatory and antiviral properties — inhibited the coronavirus in laboratory experiments, but has not been proven effective in humans, particularly in placebo-controlled, randomised clinical trials considered the gold standard for data. Surgisphere said in a statement that the audit “will bring further transparency to our work further highlight the quality of our work.” Earlier on Tuesday, the New England Journal of Medicine said it was concerned about the quality of the data behind a different study it published in May that also used data from Surgisphere and had the same lead author.

Trial Data Trump Trials Clinical Trials Study Clinical Lancet Hydroxychloroquine Surgisphere  resume  study  clinical  coronavirus  trump  covid19  trials  medicine  data  hydroxychloroquine  lancet  trial

History of this topic

"Hundreds" of Dutch died from hydroxychloroquine side effects during Covid pandemic
1 year ago

"Hundreds" of Dutch died from hydroxychloroquine side effects during Covid pandemic

NL Times  

In the early phase of the coronavirus pandemic, several hundred Dutch people died from the side effects of hydroxychloroquine, the malaria drug that seemed promising against COVID-19. And laboratory research showed that this drug might work.” Of the COVID-19 patients treated in Dutch hospitals, an estimated 10,000 or so were given hydroxychloroquine, and about 2,000 ultimately died, Bonten said. “If …

Posts mislead on Mayo Clinic’s hydroxychloroquine webpage
55 years ago

Posts mislead on Mayo Clinic’s hydroxychloroquine webpage

Associated Press  

CLAIM: The Mayo Clinic “quietly” updated its website in 2023 to say that hydroxychloroquine can now be used to treat COVID-19. A page about hydroxychloroquine on the hospital system’s website included outdated guidance that the malaria drug “may also be used to treat coronavirus in certain hospitalized patients.” But archives show the text has been there since at least May …

FDA revokes authorization for key anti-COVID drug, a blow for vulnerable Americans
1 year, 11 months ago

FDA revokes authorization for key anti-COVID drug, a blow for vulnerable Americans

LA Times  

A two-shot dose of Evusheld at a University of Washington Medicine clinic in Seattle. For her patients, she said, “it was kind of like being told the seat belts in your car won’t work anymore, and we’re not going to be able to replace them with anything.” In recent months, nine new subvariants of the dominant Omicron strain have proven …

COVID treatments weren’t suppressed to OK vaccines’ emergency use
55 years ago

COVID treatments weren’t suppressed to OK vaccines’ emergency use

Associated Press  

CLAIM: Ivermectin and hydroxychloroquine were suppressed as COVID-19 treatments because the vaccines couldn’t receive emergency use authorization if such treatments were available. THE FACTS: Social media users are sharing a conspiracy theory that posits that the drugs hydroxychloroquine and ivermectin were withheld as COVID-19 treatments by officials in order to greenlight vaccines under emergency use authorization. An emergency use authorization, …

Panel: Trump staffers pushed unproven COVID treatment at FDA
2 years, 4 months ago

Panel: Trump staffers pushed unproven COVID treatment at FDA

Associated Press  

WASHINGTON — Officials in the Trump White House tried to pressure U.S. health experts into reauthorizing a discredited COVID-19 treatment, according to a congressional investigation that provides new evidence of that administration’s efforts to override Food and Drug Administration decisions early in the pandemic. But Hahn told investigators that he felt pressure due to the “persistence” of Trump aide Peter …

Man who was in medically induced coma hails Covid drug trial for survival
2 years, 6 months ago

Man who was in medically induced coma hails Covid drug trial for survival

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email SIGN UP I would like to be emailed about offers, events and updates from The Independent. His wife enrolled him in the Recovery trial for dexmethasone, which is now estimated to …

WHO adds new drugs to COVID treatments amid Omicron surge
2 years, 11 months ago

WHO adds new drugs to COVID treatments amid Omicron surge

Al Jazeera  

Latest recommendations prompt new calls for patent waivers to allow more people access to treatments. The drug baricitinib, which is also used to treat rheumatoid arthritis, is “strongly recommended” for patients with severe or critical COVID-19, in combination with corticosteroids, the UN agency’s panel of international experts said in the guidelines which were published by the British Medical Journal on …

Merck’s COVID-19 pill narrowly wins FDA panel’s support
3 years, 1 month ago

Merck’s COVID-19 pill narrowly wins FDA panel’s support

LA Times  

An FDA panel voted 13 to 10 to recommend authorization of Merck’s experimental COVID-19 drug, molnupiravir, on Tuesday — with many caveats. Harvard infectious disease specialist Dr. Lindsey R. Baden, who chairs the FDA advisory committee, called molnupiravir’s apparent effectiveness “wobbly.” He said his own decision to recommend that the FDA grant emergency-use authorization was “incredibly difficult” in light of …

Merck’s COVID pill shows lower efficacy in updated study
3 years, 1 month ago

Merck’s COVID pill shows lower efficacy in updated study

Al Jazeera  

Drugmaker says final analysis of trial results showed molnupiravir led to 30 percent reduction in hospitalisations and deaths, compared with about 50 percent in interim study. Drugmaker Merck’s experimental COVID-19 pill is significantly less effective in slashing hospitalisations and deaths than previously reported, the company has said, following the release of a full analysis of trial results. The United States-based …

UK approves Merck’s antiviral COVID-19 pill in world first move
3 years, 2 months ago

UK approves Merck’s antiviral COVID-19 pill in world first move

Al Jazeera  

Merck’s molnupiravir to be given to recently-infected COVID-19 patients twice a day, for five days. The United Kingdom has become the first country in the world to approve a potentially game-changing COVID-19 antiviral pill jointly developed by Merck and Ridgeback Biotherapeutics. Merck’s molnupiravir has been closely watched since data last month showed it could halve the chances of dying or …

2 Indian Firms Seek Regulator Nod to Cease Trials of anti-Covid Pill Molnupiravir on 'Moderate' Patients
3 years, 3 months ago

2 Indian Firms Seek Regulator Nod to Cease Trials of anti-Covid Pill Molnupiravir on 'Moderate' Patients

News 18  

Two pharmaceutical companies have sought permission from India’s drug regulator to discontinue the phase III trials of American firm Merck & Co’s experimental antiviral drug molnupiravir in moderate Covid-19 patients, a government document shows, though one of the two manufacturers told News18.com that the “results have come out exceedingly well” in mild cases. Aurobindo Pharma and MSN Laboratories have presented …

EXPLAINED: A Pill You Can Pop At Home To Beat Covid. Here's Why Merck's Antiviral Drug Is Raising Hopes
3 years, 3 months ago

EXPLAINED: A Pill You Can Pop At Home To Beat Covid. Here's Why Merck's Antiviral Drug Is Raising Hopes

News 18  

The global death toll from Covid-19 is said to now have crossed 5 million even as the pandemic’s end is yet to appear within sight. Merck, which has partnered the US-based Ridgeback Biotherapeutics for the development of the drug, said that Phase-3 trials showed that it “significantly reduced the risk of hospitalisation or death… in at risk, non-hospitalised adult patients …

Explained | Molnupiravir, Merck’s new drug to treat COVID-19
3 years, 3 months ago

Explained | Molnupiravir, Merck’s new drug to treat COVID-19

The Hindu  

Why is there much excitement about molnupiravir, the investigational new drug for COVID-19? Pharmaceutical major Merck and Ridgeback Biotherapeutics announced via a press release on October 1 the early results from Phase-3 trials that its anti-viral drug molnupiravir halved the chances of hospitalisation in COVID-19 patients with mild or moderate disease. Several noted clinicians have said that these are promising …

WHO trial to study potential of 3 anti-malarial drugs against Covid
3 years, 4 months ago

WHO trial to study potential of 3 anti-malarial drugs against Covid

India TV News  

The World Health Organisation has announced a clinical trial to study three antimalarial and anti-inflammatory drugs as potential treatments for patients with Covid. The drugs -- artesunate, imatinib, and infliximab -- were selected by an independent expert panel for their potential in reducing the risk of death in hospitalized Covid-19 patients, the WHO said in a statement. "Finding more effective …

WHO Tests 3 Drugs for Treating Coronavirus Infection
3 years, 4 months ago

WHO Tests 3 Drugs for Treating Coronavirus Infection

News 18  

The World Health Organization says it will soon test three drugs used for other diseases to see if they might help patients sickened by the coronavirus. In a statement on Wednesday, the U.N. health agency says the three drugs would be adopted into the next phase of its ongoing global research into identifying potential treatments for COVID-19. The drugs were …

Anti-malarial drug shows promise in treating Covid-19
3 years, 6 months ago

Anti-malarial drug shows promise in treating Covid-19

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy As governments around the world race to vaccinate their populations, scientists …

Remember Donald Trump-touted hydroxychloroquine? Study in India backs it as Covid-19 cure
3 years, 7 months ago

Remember Donald Trump-touted hydroxychloroquine? Study in India backs it as Covid-19 cure

India Today  

Hydroxychloroquine, the malaria drug touted as a magical Covid-19 cure by former US President Donald Trump last year, has been found effective in a prophylactic study published in the Journal of The Association of Physicians of India last week. The study said, “hen adjusted for other risk factors, HCQ dose as per government recommendations, 2-3, 4-5, 6 or more weeks …

WHO to restart Covid drug trial with focus on immune responses
3 years, 8 months ago

WHO to restart Covid drug trial with focus on immune responses

India TV News  

The World Health Organization is set to restart an international clinical trial of three existing drugs that can save the lives of people hospitalised with Covid-19. The latest trial will test three drugs that dampen inflammation -- Infliximab, Imatinib and Artesunate. And we need to study drugs that we can deliver in a broad group of countries," added Rottingen, who …

Do not use 'miracle cure' ivermectin on COVID-19 patients says WHO
3 years, 9 months ago

Do not use 'miracle cure' ivermectin on COVID-19 patients says WHO

Firstpost  

The World Health Organization said Wednesday that ivermectin — touted by some on social media as a Covid-19 “miracle cure” — should not be used to treat coronavirus patients. The WHO said: “We recommend not to use ivermectin in patients with Covid-19 except in the context of a clinical trial.” Facebook posts and articles endorsing ivermectin have proliferated in Brazil, …

Hydroxychloroquine shouldn’t be used as Covid preventive, says WHO
3 years, 10 months ago

Hydroxychloroquine shouldn’t be used as Covid preventive, says WHO

Hindustan Times  

Anti-inflammatory drug hydroxychloroquine should not be used in efforts to prevent infection with Covid-19, according to the World Health Organization. Hydroxychloroquine was touted as a Covid-19 treatment by former President Donald Trump and later deemed ineffective. The WHO’s recommendation is based on evidence from six randomized controlled trials with more than 6,000 participants with or without known exposure to a …

Doctors test popular anti-depressant to see if it fights off Covid-19
3 years, 11 months ago

Doctors test popular anti-depressant to see if it fights off Covid-19

CNN  

CNN — Doctors are running a clinical trial to see if a popular anti-depressant might keep someone from becoming severely ill with Covid-19. Inflammation plays a key role in Covid-19, resulting in complications such as blood clots and swollen “Covid toes.” In order to get results in weeks instead of months – an important time difference while thousands are dying …

Trial comprising single Covid patient with genetic disorder shows remdesivir's benefits: Study
4 years ago

Trial comprising single Covid patient with genetic disorder shows remdesivir's benefits: Study

India Today  

Gilead's antiviral drug remdesivir could be highly effective against coronavirus, a study conducted by British scientists has found. The study, published in the journal Nature Communications involved a single Covid-19 patient with XLA, a rare genetic disorder. Nicholas Matheso, a co-author of the study, told news agency Reuters, "Our patient's unusual condition gave us a rare insight into the effectiveness …

WHO Suspends Remdesivir from List of COVID-19 Treatment Medicines
4 years, 1 month ago

WHO Suspends Remdesivir from List of COVID-19 Treatment Medicines

The Quint  

In July, Gilead priced Remdesivir at $2,340 for a five-day treatment in the US and some other developed countries, reported Al Jazeera. The WHO panel said, however, that it supported continued enrolment into clinical trials evaluating Remdesivir in patients with COVID-19, which it said should “provide higher certainty of evidence for specific groups of patients”. The WHO’s recommendation is not …

WHO suspends remdesivir from list of medicines after warning against use on Covid-19 patients
4 years, 1 month ago

WHO suspends remdesivir from list of medicines after warning against use on Covid-19 patients

India Today  

The World Health Organisation has suspended Gilead’s remdesivir, the popular antiviral medicine that was initially being touted as a potential treatment for Covid-19 cases for months, from its list of medicines. According to Reuters, WHO said on Friday it has suspended Gilead's remdesivir from its so-called prequalification list, an official list of medicines used as a benchmark for procurement by …

ICMR may remove plasma therapy from Covid-19 treatment guidelines
4 years, 2 months ago

ICMR may remove plasma therapy from Covid-19 treatment guidelines

Live Mint  

New Delhi: The government is planning to delete convalescent plasma therapy from the national guidelines for covid-19 treatment after the Indian Council of Medical Research’s clinical trial showed that the therapy did not significantly benefit patients suffering from the disease, ICMR DG Balram Bhargava said on Tuesday. ICMR, which is the government’s apex bio-medical research agency, had conducted a 464 …

Remdesivir useless in covid fight: WHO
4 years, 2 months ago

Remdesivir useless in covid fight: WHO

Live Mint  

A World Health Organization trial of Gilead Sciences Inc.’s remdesivir, the antiviral drug used to treat US President Donald Trump, showed little or no effect on the survival rates of covid patients, a result that is in variance with the trial reports of the drugmaker. The WHO trial, which also studied the effect of hydroxychloroquine, a combination of HIV drugs …

WHO Solidarity Trials find Remdesivir, HCQ, HIV drug, interferon ineffective in treating COVID-19
4 years, 2 months ago

WHO Solidarity Trials find Remdesivir, HCQ, HIV drug, interferon ineffective in treating COVID-19

Firstpost  

The WHO’s Solidarity Therapeutics Trial was conducted in 11,266 adult patients in 405 hospitals across more than 30 countries. The World Health Organization’s Solidarity trial is the world’s largest ongoing randomized control trial of potential COVID-19 therapeutics. Based on data collected from the trial, the WHO has released an interim report of patients’ responses to repurposed drugs for COVID-19 treatment. …

WHO trial results show remdesivir has little or no effect for covid-19 patients
4 years, 2 months ago

WHO trial results show remdesivir has little or no effect for covid-19 patients

Live Mint  

Interim results from the World Health Organization’s solidarity trial showed that Gilead Sciences Inc’s remdesivir showed little or no effect for covid-19 patients, a result which was significantly different from the positive results shown by Gilead’s own trial. “These remdesivir, hydroxychloroquine, lopinavir and interferon regimens appeared to have little or no effect on hospitalized covid-19 patients, as indicated by overall …

Coronavirus | Repurposed drugs did not cut down mortality, says WHO
4 years, 2 months ago

Coronavirus | Repurposed drugs did not cut down mortality, says WHO

The Hindu  

Interim results from the Solidarity Therapeutics Trial, coordinated by the World Health Organization, have indicated that remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon regimens appeared to have little or no effect on 28-day mortality or the in-hospital course of COVID-19 among hospitalised patients as per information released by the World Health Organisation. Speaking exclusively to The Hindu, about the outcome Prof. K …

WHO: Study finds four drugs that have little to no effect on coronavirus, including remdesivir
4 years, 2 months ago

WHO: Study finds four drugs that have little to no effect on coronavirus, including remdesivir

India Today  

The World Health Organisation announced Friday the long-awaited results of its six-month “Solidarity Therapeutics Trial” that endeavored to see if existing drugs might have an effect on the coronavirus. What the study found The study, which was not peer-reviewed, found that four treatments tested - remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon - had “ little or no effect" on whether or …

WHO trial finds remdesivir has little effect on COVID-19
4 years, 2 months ago

WHO trial finds remdesivir has little effect on COVID-19

Al Jazeera  

Early results from large, randomised trial suggest antiviral does little to reduce mortality rates or time in hospital. A World Health Organization trial using four drugs including the antiviral remdesivir in the hospital treatment of COVID-19 has found the repurposed medicines have little to no effect on the length of time patients spend in hospital or their survival. “These Remdesivir, …

Hydroxycloroquine does not help with Covid mortality; Improves ICU risk
4 years, 2 months ago

Hydroxycloroquine does not help with Covid mortality; Improves ICU risk

NL Times  

Hydroxychloroquine, a malaria drug often used to treat Covid-19, does not have a noticeable effect on the mortality rate of the coronavirus, according to a study by 14 Dutch hospitals. The hospitals analyzed 1,064 Covid-19 patients in 14 hospitals, 189 of whom were treated with hydroxychloroquine, 377 were treated with chloroquine, and 498 were not treated with either of the …

Anti-malaria drug hydroxychloroquine ineffective against coronavirus, reveal UK RECOVERY Trials
4 years, 3 months ago

Anti-malaria drug hydroxychloroquine ineffective against coronavirus, reveal UK RECOVERY Trials

Firstpost  

The results of the study, published by NEJM, showed that COVID-19 patients who did not need mechanical ventilation to begin with had a higher likelihood of needing ventilation or dying when they were put on hydroxychloroquine Hydroxychloroquine is no better than usual care in reducing the chances of death in COVID-19 patients, suggest the results of RECOVERY Trials published Thursday …

Healthwise: Study casts more doubt on HCQ’s effectiveness on Covid-19
4 years, 3 months ago

Healthwise: Study casts more doubt on HCQ’s effectiveness on Covid-19

Hindustan Times  

Hydroxychloroquine does not prevent infection from the new coronavirus, the virus that causes the coronavirus disease, found yet another fresh study that dismisses the effectiveness of the anti-malarial drug in protecting healthy people who are at risk of exposure to the virus. Giving HCQ 600 mg per day as a prophylaxis to physicians, nurses, certified nursing assistants, emergency technicians, and …

Re-purposed Hydroxychloroquine Being Used for Mild, Moderate Covid-19 Cases: Harsh Vardhan
4 years, 3 months ago

Re-purposed Hydroxychloroquine Being Used for Mild, Moderate Covid-19 Cases: Harsh Vardhan

News 18  

Re-purposed hydroxychloroquine is being used for mild but high risk and moderate COVID-19 cases, Union Health Minister Harsh Vardhan said in Rajya Sabha on Tuesday. “One prophylactic trial of Aswagandha and three trials of Guduchi + Pippali; Yashtimadhu; and polyherbal AYUSH drug are planned on moderately ill Covid19 patients,” he said. Government action of nationwide lockdown, community involvement etc has …

Coronavirus | Oxford vaccine trials to resume in U.K.
4 years, 3 months ago

Coronavirus | Oxford vaccine trials to resume in U.K.

The Hindu  

Oxford University in a statement Saturday has said it is resuming the ‘paused’ vaccine trial of the ChAdOx1 COVID vaccine in clinical trial sites in the United Kingdom. With a slogan to to drive home his point, Mr Modi said, “ Jab tak dawai nahi, tab tak dhilai nahi’.” Adequate review “On Sunday our standard review process triggered a study …

Coronavirus | Vaccine trial volunteer had neurological symptoms, says AstraZeneca CEO
4 years, 4 months ago

Coronavirus | Vaccine trial volunteer had neurological symptoms, says AstraZeneca CEO

The Hindu  

AstraZeneca said a woman in the United Kingdom had symptoms consistent with a rare but serious spinal inflammatory disorder, which led to the British drugmaker's decision to stop its clinical study of the new coronavirus vaccine, Stat News reported on Wednesday. The participant was recovering and will likely be discharged from the hospital as early as today, according to Stat …

Steroids can be lifesaving for a few seriously ill COVID-19 patients, new studies suggests
4 years, 4 months ago

Steroids can be lifesaving for a few seriously ill COVID-19 patients, new studies suggests

Firstpost  

WHO warned against indiscriminate use of steroids, emphasizing that patients who are not severely ill are unlikely to benefit and may suffer side effects. International clinical trials published Wednesday confirm the hope that cheap, widely available steroid drugs can help seriously ill patients survive COVID-19, the illness caused by the coronavirus. Based on the new evidence, the World Health Organization …

Drug cocktail touted by Trump to treat coronavirus increases chance of death by 27%, study shows
4 years, 4 months ago

Drug cocktail touted by Trump to treat coronavirus increases chance of death by 27%, study shows

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy A combination of drugs touted by US president Donald Trump as …

Amsterdam study shows hydroxychloroquine ineffective in Covid-19 treatment
4 years, 4 months ago

Amsterdam study shows hydroxychloroquine ineffective in Covid-19 treatment

NL Times  

Hydroxychloroquine was not effective in treating Covid-19 in Dutch hospitals during the coronavirus crisis, according to a study by Amsterdam scientists led by internist-infectiologist Edgar Peters of Amsterdam UMC. The Amsterdam researchers compared seven hospitals where Hydroxychloroquine was included in the treatment guideline in the early months of the crisis, to two hospitals where the drug was not prescribed. In …

Everything you wanted to know about covid-19 treatments, in five charts
4 years, 5 months ago

Everything you wanted to know about covid-19 treatments, in five charts

Live Mint  

When India’s National Task Force on COVID-19 recommended against including Itolizumab, Biocon’s psoriasis drug, in its treatment guidelines, the move represented two key aspects of the global scramble for a cure for covid-19 - the problematic bar for evidence, as well as the sheer size of the challenge. Perhaps no drug candidate in the race for a cure for covid-19 …

Where are we in finding a treatment for COVID-19?
4 years, 5 months ago

Where are we in finding a treatment for COVID-19?

Al Jazeera  

Some drugs and treatments have shown promise in clinical trials, while others are drawing controversy. More information on the efficacy of remdesivir in patients with COVID-19 is expected from large clinical trials such as the WHO-coordinated Solidarity Trial and the Recovery Trial in the United Kingdom. “It’s really important that these drugs be evaluated in robust clinical trials before being …

West Bengal Govt Issues New Guidelines on Treating Covid-19 Patients With Comorbidities
4 years, 5 months ago

West Bengal Govt Issues New Guidelines on Treating Covid-19 Patients With Comorbidities

News 18  

The West Bengal government has issued a new set of guidelines on treating COVID-19 patients with comorbidities, usage of repurposed drugs and post-discharge care. The new protocols, issued by the health department, was prepared following recommendations of experts who have been visiting several private and state-run COVID facilities, officials said. The department also gave its consent to using convalescent plasma …

Hydroxychloroquine is a poor coronavirus treatment but a perfect parable for our times
4 years, 5 months ago

Hydroxychloroquine is a poor coronavirus treatment but a perfect parable for our times

ABC  

The group had all the trappings of medical authority. Since March 1, public posts containing the word "hydroxychloroquine" have received at least 55 million "interactions" on Facebook — a measure that includes reactions, shares or comments. And in the months since, President Trump and members of his administration have repeatedly returned to the hydroxychloroquine narrative despite the protests of White …

Hydroxychloroquine: Researchers publish scathing critique of Henry Ford study touted by the White House
4 years, 5 months ago

Hydroxychloroquine: Researchers publish scathing critique of Henry Ford study touted by the White House

CNN  

CNN — Researchers on Wednesday published scathing critiques of a study President Trump repeatedly touted on Twitter. “The highly respected Henry Ford Health System just reported, based on a large sampling, that HYDROXYCHLOROQUINE cut the death rate in certain sick patients very significantly. For example, the patients in the Henry Ford study who were given hydroxychloroquine had fewer risk factors …

Trump Defends Use of Hydroxychloroquine, Says It Works in Early Stages of Covid-19 Infection
4 years, 5 months ago

Trump Defends Use of Hydroxychloroquine, Says It Works in Early Stages of Covid-19 Infection

News 18  

US President Donald Trump has again defended the use of hydroxychloroquine to ward off coronavirus, saying many frontline medical workers agree with him that the malaria drug works in the early stages of COVID-19 infection, despite mounting evidence that it is ineffective in treating the disease. I think frontline medical people believe that too — some, many," Trump told reporters …

Video falsely touts hydroxychloroquine as COVID-19 cure
4 years, 5 months ago

Video falsely touts hydroxychloroquine as COVID-19 cure

Associated Press  

CLAIM: A video makes numerous claims about preventing the coronavirus, stating that hydroxychloroquine can prevent and cure COVID-19, and wearing masks and keeping people locked down have no value. “There is no evidence done in a rigorous study that shows hydroxychloroquine in combination with azithromycin or zinc or whatever combination you use that has any benefit in the treatment of …

Trump again pushes unproven hydroxychloroquine as Covid-19 treatment
4 years, 5 months ago

Trump again pushes unproven hydroxychloroquine as Covid-19 treatment

Live Mint  

WASHINGTON: A week after appearing to project a more serious tone about the coronavirus, President Donald Trump is back to pushing unproven claims that an anti-malaria drug is an effective treatment and challenging the credibility of the nation's leading infectious disease expert. The president also shared a post from the Twitter account for a podcast hosted by Steve Bannon, a …

Scientists identify 21 existing drugs that block coronavirus in lab studies
4 years, 5 months ago

Scientists identify 21 existing drugs that block coronavirus in lab studies

Live Mint  

Scientists, including those of Indian-origin, have identified 21 existing drugs that stop the replication of the novel coronavirus which causes COVID-19 in lab studies, an advance that may lead to the development of new therapeutic combinations against the disease. Of the 21 drugs that were effective at blocking viral replication, the scientists found that 13 have previously entered clinical trials …

Coronavirus | India’s actual case load of COVID-19 stands at 4,26,167 active patients: Health Ministry
4 years, 5 months ago

Coronavirus | India’s actual case load of COVID-19 stands at 4,26,167 active patients: Health Ministry

The Hindu  

India’s actual case load of COVID-19 stands at 4,26,167 active patients with a fatality rate of 2.41% and recovery rate at 63.18 %, according to figures released by the Union Health Ministry here on Thursday. Higher number of patients getting cured and discharged has contributed to the increasing gap between recovered and the active cases. Keep a safe distance from …

Discover Related